Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
12 December 2009 - 1:20AM
PR Newswire (US)
BEIJING, Dec. 11 /PRNewswire-Asia-FirstCall/ -- Concord Medical
Services Holdings Limited (NYSE:CCM) ("CMS" or "the Company"),
operator of the largest network of radiotherapy and diagnostic
imaging centers in China in terms of revenues and the total number
of centers in operation in 2008, announced today that its initial
public offering of 12,000,000 American Depositary Shares ("ADSs"),
each representing three ordinary shares of the Company, was priced
at $11.00 per ADS. Net proceeds from the sale of the ADSs are
approximately $119.5 million. The ADSs are expected to begin
trading on the New York Stock Exchange on December 11, 2009 under
the symbol "CCM." The Company intends to use the proceeds from the
offering to expand its network of radiotherapy and diagnostic
imaging centers, to develop two new specialty cancer hospitals, and
for general corporate purposes. Certain of the Company's
shareholders have granted the underwriters a 30-day option to
purchase up to an additional 1,800,000 ADSs to cover
over-allotments, if any. Morgan Stanley & Co. International
plc, J.P. Morgan Securities Inc. and China International Capital
Corporation Hong Kong Securities Limited acted as joint bookrunners
for the offering. CMS's registration statement relating to these
securities has been declared effective by the United States
Securities and Exchange Commission (the "SEC"). This press release
shall not constitute an offer to sell or the solicitation of an
offer to buy, nor shall there be any sale of these securities in
any state or other jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or jurisdiction. The
offering of these securities is made only by means of a written
prospectus forming a part of the effective registration statement.
A copy of the prospectus relating to the offering may be obtained
by visiting EDGAR on the SEC's web site at http://www.sec.gov/ ; by
contacting Morgan Stanley & Co at 180 Varick Street, New York,
New York 10014, attention: Prospectus Department, or by calling
(866) 718 1649, or by emailing ; by contacting J.P. Morgan at J.P.
Morgan Securities Inc., c/o Broadridge Financial Solutions, 1155
Long Island Avenue, Edgewood, New York 11717, or by calling
1-866-803-9204; or by contacting China International Capital
Corporation at 350 Park Avenue, 28th floor, New York, New York
10022, or by calling +852 2872-2000. About Concord Medical Services
Holdings Limited CMS operates China's largest network of
radiotherapy and diagnostic imaging centers in terms of revenues
and the total number of centers in operation in 2008. Since its
establishment, CMS has been committed to building an extensive
network of radiotherapy and diagnostic imaging centers in China
that employ advanced medical technology to sustain lives and reduce
suffering. Today, the Company operates a network of more than 80
centers spanning 36 cities and 21 provinces and administrative
regions in China. Safe Harbor Statement This press release contains
statements that may constitute "forward-looking" statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements involve a
number of risks and uncertainties that could cause actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
these forward-looking statements. Further information regarding
these and other risks is included in the Company's filings with the
SEC, including its registration statement on Form F-1, as amended
from time to time. The Company does not undertake any obligation to
update any forward-looking statement as a result of new
information, future events or otherwise, except as required under
applicable law. For more information, please contact: Integrated
Corporate Relations, Inc. In New York: Ashley M. Ammon Tel:
+1-646-277-1227 In Beijing: Michael Tieu Tel: +86-10-6599-7968
Email: DATASOURCE: Concord Medical Services Holdings Limited
CONTACT: in New York, Ashley M. Ammon, +1-646-277-1227, or in
Beijing, Michael Tieu, +86-10-6599-7968, , both of Integrated
Corporate Relations, Inc., for Concord Medical Services Holdings
Limited
Copyright